Literature DB >> 3596168

Cigarette smoking and inflammatory bowel disease.

M V Tobin, R F Logan, M J Langman, R B McConnell, I T Gilmore.   

Abstract

In a case-control study 280 patients with inflammatory bowel disease and matched community controls taken from general practitioner lists were questioned about their smoking habits. Whether assessed by current or previous habits, patients with Crohn's disease were more likely to be or have been smokers than their matched controls and the association appeared strongest at disease onset (matched relative risk 4.1, p less than 0.001). In contrast, patients with ulcerative colitis assessed in the same way were less likely to be smokers compared with their matched controls, with the association being equally strong at disease onset and currently (matched relative risk 0.17, p less than 0.001). Among patients with ulcerative colitis who were exsmokers, 76% reported stopping smoking before disease onset compared with 13% of exsmokers with Crohn's disease. Contrary to earlier reports, there were only small and nonsignificant increases in the risk of Crohn's disease or ulcerative colitis in exsmokers. The strength, temporal precedence, and contrasting nature of the associations are evidence that smoking has an important etiologic role in inflammatory bowel disease. Smoking appears to be a factor in determining whether Crohn's disease or ulcerative colitis develops in predisposed individuals.

Entities:  

Mesh:

Year:  1987        PMID: 3596168     DOI: 10.1016/0016-5085(87)91021-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  53 in total

1.  Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study.

Authors:  Giovanni Maconi; Sandro Ardizzone; Claudia Cucino; Cristina Bezzio; Antonio-Giampiero Russo; Gabriele Bianchi Porro
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

2.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

3.  A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women.

Authors:  Leslie M Higuchi; Hamed Khalili; Andrew T Chan; James M Richter; Athos Bousvaros; Charles S Fuchs
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

Review 4.  Recent epidemiology of ulcerative colitis and Crohn's disease.

Authors:  J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 5.  Cigarette smoking and intestinal defences.

Authors:  G F Cope; R V Heatley
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

6.  (E)-metanicotine hemigalactarate (TC-2403-12) inhibits IL-8 production in cells of the inflamed mucosa.

Authors:  Tanja Spoettl; Christine Paetzel; Hans Herfarth; Merouane Bencherif; Juergen Schoelmerich; Roland Greinwald; Gregory J Gatto; Gerhard Rogler
Journal:  Int J Colorectal Dis       Date:  2006-05-20       Impact factor: 2.571

Review 7.  The role of smoking in Crohn's disease as defined by clinical variables.

Authors:  Suhal S Mahid; Kyle S Minor; Patrick L Stevens; Susan Galandiuk
Journal:  Dig Dis Sci       Date:  2007-03-31       Impact factor: 3.199

8.  Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study.

Authors:  S A Mitchell; M Thyssen; T R Orchard; D P Jewell; K A Fleming; R W Chapman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation.

Authors:  G Fortin; K Yurchenko; C Collette; M Rubio; A-C Villani; A Bitton; M Sarfati; D Franchimont
Journal:  Clin Exp Immunol       Date:  2009-01-23       Impact factor: 4.330

10.  Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis.

Authors:  Jan Seibel; Almut F Molzberger; Torsten Hertrampf; Ute Laudenbach-Leschowski; Patrick Diel
Journal:  Eur J Nutr       Date:  2009-02-21       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.